Tradestie Institutional Equity Comparison Engine

BHST vs GLPG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GLPG Overall Edge

GLPG Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Galapagos NV (GLPG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus GLPG at N/M Forward P/E and 88.0% operating margin (+1093.2% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GLPG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GLPG
BHST N/M vs GLPG N/M Fwd P/E
Growth & Margin Winner GLPG
Op Margin -18.0% vs 88.0% ยท YoY +3.8% vs +1093.2%
Momentum & Technical Winner GLPG
1Y -79.4% vs +5.6% ยท 52W Pos 6% vs 23%
Options & Structure Winner GLPG
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (2nd %ile IV)
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
GLPG NASDAQ
Galapagos NV
Pharmaceutical Preparations
$27.73
-3.75% 1D
Market Cap $1.9B
1M Return -4.02%
1Y Return +5.56%
Forward P/E N/M
Unified AI Score
61.5 / 100 BUY
Tech 45.0 Fund 52.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHST -79.4% GLPG +5.56% Spread: +25.82 pp (GLPG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHST TTM Op. Margin: -18.0% GLPG TTM Op. Margin: 88.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHST vs GLPG. Trailing 12-month operating profitability (BHST -18.0% vs GLPG 88.0%) and valuation multiples (BHST N/M vs GLPG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHST (0) vs GLPG (9)
Institutional Metric BHST GLPG Criterion Row Winner
Market Capitalization Scale $29.9M $1.9B Larger Scale GLPG
Trailing P/E Ratio Valuation N/M 5.1x Lower Multiple GLPG
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +3.8% +1093.2% Higher Growth GLPG
Operating Margin (TTM) Profitability -18.0% 88.0% Higher Margin GLPG
Net Profit Margin Profitability -31.2% 28.8% Higher Margin GLPG
Return on Equity (ROE) Capital Efficiency -142.5% 10.4% Higher ROE GLPG
52-Week Range Position Momentum 6% ($1โ€“$7) 23% ($25โ€“$38) Stronger Trend GLPG
Beta / 30D Volatility Risk Regime 0.25ฮฒ ยท 86% Vol 0.71ฮฒ ยท 20% Vol Lower Realized Risk GLPG
Unified Institutional Score Composite Signal 58.2 / 100 (HOLD) 61.5 / 100 (BUY) Higher Composite GLPG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHST vs GLPG Buy Guide
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GLPG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live GLPG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHST nor GLPG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.